Understanding the Pathophysiology of Cerebral Amyloid Angiopathy

Laura Gatti(Fondazione IRCCS Istituto Neurologico Carlo Besta), Anna Bersano(Fondazione IRCCS Istituto Neurologico Carlo Besta)

International Journal of Molecular Sciences

May 13, 2020

10.3390/ijms21103435

Cited by 86

Related Papers

Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma

|Frontiers in Cell and Developmental Biology|2022|35

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

|Oncotarget|2014|30